Use of Crowdsourcing for Cancer Clinical Trial Development
Amanda Leiter(Icahn School of Medicine at Mount Sinai), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Michael A. Diefenbach(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), William Oh(Eunice Kennedy Shriver National Institute of Child Health and Human Development), John J. Holland(Los Angeles Clinical Trials), Marc Foster(Los Angeles Clinical Trials), Tomasz Sablinski(Icahn School of Medicine at Mount Sinai), Alex M. Greenberg(Los Angeles Clinical Trials)
Cited by 44
Related Papers
Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
|New England Journal of Medicine|2005|2.8k
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
|PEDIATRICS|2002|2.4k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k